Cinnarizine in the prophylactic treatment of childhood migraine: a comparison with propranolol
Not Applicable
Completed
- Conditions
- Headache severity recorded on a three scale,and was defined as mild (no effect on daily activities),moderate (disrupts daily activities),severe (requiring immediate intervention and treatment). Furchildrenmigraineheadachecinnarizinepropranololclinical trial
- Registration Number
- TCTR20180903005
- Lead Sponsor
- Hormozgan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 56
Inclusion Criteria
Children aged 6-14 years who had migraine with and without aura, defined by the International International Headache Society criteria for migraine (17), were enrolled into the study. All patients experienced one or more headaches per week for at least 6 months or had severe disabling or intolerable headache before entry into the study.
Exclusion Criteria
children who had complicated migraine that required medications other than analgesics, past treatment with migraine prophylactic agent, persistent increasing headache,
comorbid conditions such as seizures, abnormal neuroimaging, history of epilepsy, and history of contraindications to cinnarizine or propranolol administration.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method compare the efficacy of cinnarizine with propranolol in the prophylaxis of pediatric migraine headac 2-month follow-up The frequency, severity of headaches
- Secondary Outcome Measures
Name Time Method /A - N/A